No connection

Search Results

BFLY vs LLY

BFLY
Butterfly Network, Inc.
NEUTRAL
Price
$4.51
Market Cap
$1.14B
Sector
Healthcare
AI Confidence
65%
LLY
Eli Lilly and Company
NEUTRAL
Price
$958.65
Market Cap
$858.01B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
BFLY
--
LLY
41.7
Forward P/E
BFLY
-32.8
LLY
22.78
P/B Ratio
BFLY
5.59
LLY
32.33
P/S Ratio
BFLY
12.88
LLY
13.16
EV/EBITDA
BFLY
-16.66
LLY
27.08

Profitability

Gross Margin
BFLY
62.92%
LLY
83.04%
Operating Margin
BFLY
-69.69%
LLY
44.9%
Profit Margin
BFLY
-90.31%
LLY
31.67%
ROE
BFLY
-41.42%
LLY
101.16%
ROA
BFLY
-14.35%
LLY
19.41%

Growth

Revenue Growth
BFLY
4.5%
LLY
42.6%
Earnings Growth
BFLY
--
LLY
51.4%

Financial Health

Debt/Equity
BFLY
0.1
LLY
1.65
Current Ratio
BFLY
4.8
LLY
1.58
Quick Ratio
BFLY
3.35
LLY
0.78

Dividends

Dividend Yield
BFLY
--
LLY
0.68%
Payout Ratio
BFLY
0.0%
LLY
26.14%

AI Verdict

BFLY NEUTRAL

Butterfly Network (BFLY) shows a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a definitive bankruptcy risk assessment. Despite deeply negative profitability metrics—including a -90.31% profit margin and negative ROE/ROA—the company maintains strong liquidity (Current Ratio: 4.80) and a low Debt/Equity ratio of 0.10. Revenue growth is modest at 4.50% YoY, but earnings surprises have been consistently positive in recent quarters, suggesting operational improvements. However, aggressive insider selling worth $21.71M over the past six months contradicts the 'strong_buy' analyst consensus and raises concerns about insider confidence.

Strengths
Strong liquidity position with Current Ratio of 4.80 and Quick Ratio of 3.35
Low leverage with Debt/Equity ratio of 0.10, well below sector average of 2.28
High gross margin of 62.92%, indicating pricing power or efficient production
Risks
Piotroski F-Score of 5 indicates borderline financial stability; not strong enough to signal robust health
Severe unprofitability: -90.31% profit margin and -41.42% ROE suggest ongoing fundamental weaknesses
Negative Forward P/E of -32.80 implies no near-term earnings recovery priced in
LLY NEUTRAL

LLY shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.

Strengths
Strong profitability (31.7% margin)
Strong revenue growth of 42.6%
Strong ROE of 101.2%
Risks
High valuation with P/E of 41.7
Premium vs Graham Number ($123.85)
Weak financial trend (Piotroski F-Score: 3/9)

Compare Another Pair

BFLY vs LLY: Head-to-Head Comparison

This page compares Butterfly Network, Inc. (BFLY) and Eli Lilly and Company (LLY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile